More articles about Biomarker Discovery & Validation

DxTerity aims to develop a genomic blood test to identify which cancer patients are most likely to benefit from radiation therapy or are at risk for toxicity.

Bioage Labs now intends to set up an internal laboratory to experiment with different compounds, while building out its team.

Data from several large cohorts suggests that a variant in LILRB5 may produce a propensity for muscle pain or myalgia, upping the risk of statin intolerance.

The company said it will use the funds to accelerate its biomarker discovery programs and further develop its cancer immunotherapy biomarker platform.

The partners aim to enable the early prediction of clinical efficacy of Alligator's pipeline candidates by analyzing potential systemic biomarkers.

Adaptive will work with NCI's Cancer Therapy Evaluation Program to use its ImmunoSeq platform for biomarker discovery in clinical trials. 

Stakeholders increasingly highlight the need for better, more standardized tools to validate and compare liquid biopsy tests, and commercial firms have responded.

Researchers reported on results for more than 100 healthy individuals who were tracked with 'omics and clinical tests over nine months.

Using the grant funding, the investigators are aiming to advance the precision diagnosis and treatment of lung cancer.

New research has identified circulating cell subtypes with ties to better or worse outcomes in individuals with prostate cancer.

The companies are aiming to identify treatment-response biomarker signatures in patients with advanced melanoma.

AstraZeneca will use Trovagene's Trovera EGFR urine liquid biopsy test in an open-label prospective biomarker study.

The partners will promote biomarker research for nutrition-related diseases in order to advance the development of new diagnostics and therapeutics.

Qiagen will use NGS to develop gene expression profiles related to BMS immuno-oncology therapies; and the company has licensed IO therapy response biomarkers from JHU.

The deal gives Celgene access to ImiDomics' database of genomic markers derived from biological samples for immune-mediated inflammatory diseases.

Inflammatix hopes to market an 18-gene panel that will be able to tell from a blood sample whether a hospitalized patient has a bacterial, viral, or no infection.

The partners aim to identify microRNAs that can be used to identify patients likely to respond to PD-L1-targeting cancer drugs.

Using small RNA sequencing, investigators found miRNAs in the blood that track with cirrhosis, hepatitis, type 2 diabetes, or acetaminophen toxicity.

The partners have formed a public/private partnership to foster collaboration and data integration between different institutes researching brain trauma.

The grant will fund a collaboration investigating whether genomic signatures and other biomarkers can be used in clinical diagnosis and monitoring of kidney cancer.

Pages

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.